BRAF and melanoma: Their results showed that these lipid nanoparticles loaded with oncosuppressor miRNAs are highly efficient in impairing melanoma cell proliferation and viability, affecting key signalling cascades involved in cell survival, in addition to positively influencing the efficacy of BRAF and MEK inhibitory drugs [154] (Table 4).